Comorbidity Burden as a Prognostic Factor for Clinical Outcomes of Combined Nuclear Magnetic Resonance Therapy and Physical Rehabilitation in Degenerative Shoulder Joint Diseases | Ukrainian Medical Journal

Fishchenko V.O.,Humeniuk O.O.

Main
Publications
Comorbidity Burden as a Prognostic Factor for Clinical Outcomes of Combined Nuclear Magnetic Resonance Therapy and Physical Rehabilitation in Degenerative Shoulder Joint Diseases

Comorbidity Burden as a Prognostic Factor for Clinical Outcomes of Combined Nuclear Magnetic Resonance Therapy and Physical Rehabilitation in Degenerative Shoulder Joint Diseases

December 10, 2025

100

Rehabilitation

Orthopedics and Traumatology

Fishchenko V.O.

Humeniuk O.O.

УДК: 616.728-007.24-085.832-085.825-036.86

DOI: 10.32471/umj.1680-3051.271697

Keywords :

degenerative-dystrophic joint diseases,

omarthrosis,

osteoarthritis,

physical rehabilitation,

prognosis,

shoulder joint

Specialities :

Rehabilitation

Orthopedics and Traumatology

Resume

Objective: to characterize the role of comorbidity as a prognostic factor for clinical outcomes of nuclear magnetic resonance therapy and McKenzie physical rehabilitation techniques in degenerative shoulder joint diseases.

Materials and methods. Treatment outcomes were analyzed in 21 cases of omarthrosis in 18 patients (11 (61.11%) men and 7 (38.89%) women; mean age — 58.28±11.59 years). The course of conservative treatment included 7 sessions of nuclear magnetic resonance therapy combined with McKenzie physical rehabilitation. Clinical outcomes were assessed using the Oxford Shoulder Score.

Results. The mean outcome corresponded to excellent values (41.29±5.18 points). Excellent results were observed in 14 (66.67%) patients, good in 6 (28.57%), and satisfactory in 1 (4.76%). Factors associated with better outcomes included male sex (τ=+0.45, p=0.004), middle age (τ=+0.40, p=0.01), and lower Charlson comorbidity index (τ=+0.35, p=0.02). Poorer results were found in older patients (τ=−0.44, p=0.005), especially in the elderly (τ=−0.42, p=0.007), with heart failure (τ=−0.52, p=0.001), peripheral vascular disease (τ=−0.60, p=0.0002), and higher Charlson index (τ=−0.51, p=0.001). Men had higher odds of achieving excellent results (OR=9.17, CI (1.00–84.35), p=0.03). Peripheral vascular disease was associated with higher odds of good results (OR 13.00, 95% CI 1.17–144.90; p=0.02).

Conclusion. Comorbidity has a significant impact on the clinical outcomes of comprehensive conservative treatment in patients with degenerative shoulder joint diseases.

References

1. Yamamoto N., Szymski D., Voss A. et al. (2023) Non-operative management of shoulder osteoarthritis: Current concepts. Journal of ISAKOS: joint disorders & orthopaedic sports medicine, 8(5): 289–295.
2. Baumann A.N., Indermuhle T., Oleson C.J. et al. (2023) Comparing Outcomes After Referral to Physical Therapy for Patients With Glenohumeral Osteoarthritis Based on the Radiographic Osteoarthritis Severity: A Retrospective Analysis. Cureus, 15(8): e43027. doi.org/10.7759/cureus.43027.
3. Hoveidaei A.H., Ghaseminejad-Raeini A., Kanaani Nejad F. et al. (2024) Rethinking the Role of Formal Physical Therapy in Glenohumeral Osteoarthritis: A Nationwide Study Comprising More than Two Million Patients in the United States. JAAOS Global Research & Reviews, 8(11): e24.00225.
4. Reddy R.P., Charles S., Solomon D.A. et al. (2022) Arthritis Severity and Medical Comorbidities Are Prognostic of Worse Outcomes Following Arthroscopic Rotator Cuff Repair in Patients With Concomitant Glenohumeral Osteoarthritis. Arthroscopy, sports medicine, and rehabilitation, 4(6): e1969–e1977. doi.org/10.1016/j.asmr.2022.08.005.
5. Tombak Y. (2024) Do Comorbidities and Body Mass Index Influence Shoulder Pain, Disability and Joint Range of Motion? J. Clin. Med. Kaz., 21(4): 52–58. doi.org/10.23950/jcmk/14973.
6. Steinecker-Frohnwieser B., Lohberger B., Eck N. et al. (2021) Nuclear Magnetic Resonance Therapy Modulates the miRNA Profile in Human Primary OA Chondrocytes and Antagonizes Inflammation in Tc28/2a Cells. Int. J. Mol. Sci., 22(11): 5959. doi.org/10.3390/ijms22115959.
7. Krpan D., Kullich W. (2017) Nuclear magnetic resonance therapy (MBST) in the treatment of osteoporosis. Case report study. Clin. Cases Miner. Bone Metab., 14(2): 235–238. doi: 10.11138/ccmbm/2017.14.1.235.
8. Krpan D. (2018) MBST — Nuclear Magnetic Resonance Therapy in the Treatment of Osteoarthritis, the Long-Term Follow Up — Case Report. Biomed. J. Sci. & Tech. Res., 11(2): 8373–8375. DOI: 10.26717/BJSTR.2018.11.002068.
9. Huels N., Harms O., Keim D. et al. (2020) Treatment of the Clinical Symptoms of Osteoarthritis in the Elbow Joints of Dogs Using Nuclear Magnetic Resonance Therapy: A Randomized, Double-Blinded Trial. Front. Vet. Sci., 7: 500278.
10. Schmidt J.K., Debess J.E., Møller L. (2021) Magnetic resonance therapy in the treatment of osteoarthritis: A scoping review. Radiography (Lond.), 27(3): 968–975. doi.org/10.1016/j.radi.2021.02.011.
11. McKenzie R., Watson G., Lindsay R. (2009) Treat Your Own Shoulder. USA: McKenzie global ltd. 96 p.
12. Dawson J., Fitzpatrick R., Carr A. (1996) Questionnaire on the perceptions of patients about shoulder surgery. J. Bone Joint Surg. Br., 78: 593–600.
13. Strafun S.S., Haiovych V.V., Zanko I.S. (2021) Comparison of Questionnaire Scales to Assess the Function of the Shoulder Joint in Patients after Unipolar Arthroplasty Visnyk Orthop Traum Protez., 4(111): 14–20.
14. Zhou X., Niu X., Mao Q., Liu Y. (2020) Clinical Significance of Various Classification Standards of Age Groups in Predicting Survival of Patients with Glioblastoma. Medical science monitor: international medical journal of experimental and clinical research, 26: e920627. doi.org/10.12659/MSM.920627.
15. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis., 40(5): 373–383.
16. The World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. http://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/.
17. Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine. zakon.rada.gov.ua/laws/show/994_334#Text.
18. Order of the Ministry of Health of Ukraine No. 690. On Approval of the Procedure for Conducting Clinical Trials of Medicinal Products and Examination of Clinical Trial Materials and Model Regulation on Ethics Committees. zakon.rada.gov.ua/laws/show/z1010-09#Text.